Therapy-activated stromal cells can dictate tumor fate
2016 ◽
Vol 213
(13)
◽
pp. 2831-2833
◽
Keyword(s):
Low Dose
◽
In this issue of JEM, Chan et al. describe a novel way by which an investigational form of chemotherapy known as low-dose metronomic chemotherapy can inhibit tumor growth, which also has therapeutic implications for targeting tumor-initiating cells (TICs), the tumor stroma, and chemokine receptors, as well as invasion and metastasis.
Keyword(s):
2013 ◽
Vol 2
(2)
◽
pp. 154-166
◽
2016 ◽
Vol 213
(13)
◽
pp. 2967-2988
◽
2020 ◽
Vol 180
(3)
◽
pp. 635-646
◽
2016 ◽
Vol 22
(14)
◽
pp. 3560-3570
◽